Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

629 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b).
Nicoletti F, Di Marco R, Patti F, Reggio E, Nicoletti A, Zaccone P, Stivala F, Meroni PL, Reggio A. Nicoletti F, et al. Among authors: nicoletti a. Clin Exp Immunol. 1998 Jul;113(1):96-9. doi: 10.1046/j.1365-2249.1998.00604.x. Clin Exp Immunol. 1998. PMID: 9697990 Free PMC article. Clinical Trial.
Prevalence of epilepsy in rural Bolivia: a door-to-door survey.
Nicoletti A, Reggio A, Bartoloni A, Failla G, Sofia V, Bartalesi F, Roselli M, Gamboa H, Salazar E, Osinaga R, Paradisi F, Tempera G, Dumas M, Hall AJ. Nicoletti A, et al. Neurology. 1999 Dec 10;53(9):2064-9. doi: 10.1212/wnl.53.9.2064. Neurology. 1999. PMID: 10599782
Prevalence of stroke : a door-to-door survey in rural Bolivia.
Nicoletti A, Sofia V, Giuffrida S, Bartoloni A, Bartalesi F, Bartolo ML, Fermo SL, Cocuzza V, Gamboa H, Salazar E, Reggio A. Nicoletti A, et al. Stroke. 2000 Apr;31(4):882-5. doi: 10.1161/01.str.31.4.882. Stroke. 2000. PMID: 10753992
Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha.
Nicoletti F, Di Marco R, Patti F, Zaccone P, L'Episcopo MR, Reggio E, Xiang M, Nicoletti A, Reggio A. Nicoletti F, et al. Among authors: nicoletti a. Cytokine. 2000 Jun;12(6):682-7. doi: 10.1006/cyto.1999.0616. Cytokine. 2000. PMID: 10843745
Prevalence and incidence of multiple sclerosis in Catania, Sicily.
Nicoletti A, Lo Bartolo ML, Lo Fermo S, Cocuzza V, Panetta MR, Marletta C, Ciancio MR, Cataldi ML, Patti F, Reggio A. Nicoletti A, et al. Neurology. 2001 Jan 9;56(1):62-6. doi: 10.1212/wnl.56.1.62. Neurology. 2001. PMID: 11148237
The antiinflammatory cytokine interleukin-13 is not detectable in the circulation of multiple sclerosis patients and is not inducible by interferon-beta1b treatment, that neither modifies its ex vivo secretion from peripheral blood mononuclear cells.
Nicoletti F, Di Marco R, Patti F, Nicoletti A, Leonardi C, Reggio E, Meroni P, Reggio A. Nicoletti F, et al. Among authors: nicoletti a. Autoimmunity. 2000 Dec;32(4):265-70. doi: 10.3109/08916930008994100. Autoimmunity. 2000. PMID: 11191285
629 results